Abstract
The gravity of cardiogenic shock may be understood through this simple statement. In this condition, the body can no longer go on functioning because of the failing heart. In contrast to Neale’s statement, however, we have made major advances in our understanding about how and why this condition occurs. Moreover, although cardiogenic shock remains an ominous condition, there is a ray of hope that the better diagnostic and therapeutic modalities currently available will result in improved outcomes.
Fails my heart, I know not how; I can go no longer
James Mason Neale (1818–1866)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR Jr. Cardiogenic shock complicating acute coronary syndromes. Lancet 2000; 356: 749–756.
Hasdai D, Califf RM, Thompson TD, et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 2000; 35: 136–143.
Holmes DR Jr, Califf RM, Van de Werf F, et al. Differences in countries’ use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet 1997; 349: 75–78.
Hasdai D, Holmes DR Jr, Califf RM, et al. Cardiogenic shock complicating acute myocardial infarction: Predictors of mortality. Am HeartJ 1999; 138: 21–31.
Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995; 26: 668–674.
Hasdai D, Harrington RA, Hochman JS, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2000; 36: 685–692.
Hasdai D, Holmes DR Jr, Topol EJ, et al. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase: results from GUSTO III. Eur Heart J 1999; 20: 128–135.
Holmes DR Jr, Berger PB, Hochman JS, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999; 100: 2067–2073.
Menon V, Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS. Acute myocardial infarction controlled by systemic hypoperfusion without hypotension: report from the SHOCK trial registry. Am J Med 2000; 108: 374–380.
Antman EM, Braunwald E. Acute myocardial infarction. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. 5th ed. WB Saunders, Philadelphia, pp. 1184–1288.
Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996; 276: 889–897.
Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction-incidence and mortality from a community wide perspective 1975–1988. N Engl J Med 1991; 325: 1117–1122.
Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340: 1162–1168.
Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912; 39: 2015–2020.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hasdai, D. (2002). Cardiogenic Shock. In: Hasdai, D., Berger, P.B., Battler, A., Holmes, D.R. (eds) Cardiogenic Shock. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-154-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-59259-154-1_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-312-1
Online ISBN: 978-1-59259-154-1
eBook Packages: Springer Book Archive